6 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
Cardiovascular and renal ... between SGLT-2 inhibitors ... (Steglatro) #diabetes ... cardiovascular #renal ... #SGLT2i #Inhibitors
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
gliflozin): • Empagliflozin ... loss (~2-3kg) • Empagliflozin ... • Euglycemic diabetic ... #Summary #DM2 #diabetes ... #endocrinology
SGLT2 inhibitors, also called gliflozins, are a class of medications that alter essential physiology of the
SGLT2 inhibitors ... that modulate sodium ... treatment of type II diabetes ... (Farxiga®) and empagliflozin ... , #empagliflozin
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
- Normal and Renal ... patients have renal ... #Renal #Dosing ... Pharmacology #Management #Diabetes ... #DM2 #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Sulfonylurea, TZD, DPP-4 inhibitor ... α-glucosidase inhibitor ... insulin dose for renal ... comparison #table #endocrinology
Hyperuricemia - Differential Diagnosis Algorithm
Primary - Over-production
     • Increased turnover of nucleotides
Primary
Hyperparathyroidism • Diabetic ... acidosis - Renal ... • Chronic renal ... drugs • ACE inhibitors ... Diagnosis #Algorithm #endocrinology